SCHEMBL21709954

SCHEMBL21709954

COc1ccc(C2(c3ccc(Sc4ccccc4)cc3)OCCO2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.43
OPRL1 P41146 1/20 0.43
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
POLB P06746 1/20 0.40
HTR2C P28335 1/20 0.40
PTGIR P43119 5/20 0.40
CA4 P22748 1/20 0.38
LTA4H P09960 1/20 0.38
MAPT P10636 3/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ALDH1A1 P00352 4/20 0.37
MMP2 P08253 1/20 0.37
MMP9 P14780 1/20 0.37
MMP12 P39900 1/20 0.37
HTR1A P08908 1/20 0.37
HTR3A P46098 1/20 0.37
SLC6A9 P48067 1/20 0.37
HPGD P15428 1/20 0.37
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21709885 0.94 OPRM1 (0.41) OPRM1OPRL1MEN1KMT2APOLB
SCHEMBL17024451 0.83 CA1 (0.48) OPRM1OPRL1KMT2APOLBMAPT
SCHEMBL21709952 0.83 CYP1A1 (0.50) MAPTALDH1A1
SCHEMBL2272158 0.80 CA4 (0.59) MEN1KMT2APOLBHTR2CPTGIR
SCHEMBL21679404 0.80 MAOA (0.38) MEN1KMT2AMAPTSMN1; SMN2ALDH1A1
SCHEMBL21709951 0.79 CYP1A1 (0.46) PTGIRMAPTSMN1; SMN2ALDH1A1
SCHEMBL12857831 0.77 ACHE (0.56) OPRM1OPRL1KMT2APOLBMAPT
SCHEMBL12857953 0.77 ACHE (0.56) OPRM1OPRL1KMT2APOLBMAPT
SCHEMBL18287951 0.77 CA1 (0.44) OPRM1OPRL1POLB
SCHEMBL16543025 0.77 CA1 (0.44) OPRM1OPRL1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11142495-B2 Composition and method for manufacturing device using same TOYO GOSEI CO., LTD. (JP) 2021-10-12 US disclosed
US-20200048191-A1 COMPOSITION AND METHOD FOR MANUFACTURING DEVICE USING SAME TOYO GOSEI CO., LTD. (JP) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200048191-A1 COMPOSITION AND METHOD FOR MANUFACTURING DEVICE USING SAME LBR, LMTK2, MMS19 OPRM1 2297/4885OPRL1 1979/4885MEN1 3312/4885
US-11142495-B2 Composition and method for manufacturing device using same LBR, LMTK2, MMS19 OPRM1 2297/4885OPRL1 1979/4885MEN1 3312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.